Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease

BACKGROUND: Somatostatin (SST) inhibits intracellular cyclic adenosine monophosphate (cAMP) production and thus may modify cyst formation in autosomal dominant polycystic kidney disease (ADPKD). We investigated whether endogenous plasma SST concentration is associated with disease severity and progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Messchendorp, A. Lianne, Spithoven, Edwin M., Casteleijn, Niek F., Dam, Wendy A., van den Born, Jacob, Tonnis, Wouter F., Gaillard, Carlo A. J. M., Meijer, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299932/
https://www.ncbi.nlm.nih.gov/pubmed/30567514
http://dx.doi.org/10.1186/s12882-018-1176-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299932/
https://www.ncbi.nlm.nih.gov/pubmed/30567514
http://dx.doi.org/10.1186/s12882-018-1176-y

Ejemplares similares